Overcoming health systems barriers to successful malaria treatment

Trends in Parasitology

Volumn 29, Issue 4, 2013, Pages 164-180

  Rao, V Bhargavi ^a   Schellenberg, David ^b   Ghani, Azra C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Artemisinin combination therapies (ACTs); Community health workers; Health systems; Interventions; Malaria; Private sector; Public sector

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ARTEMISININ;

ANTIBIOTIC THERAPY; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COMMUNITY CARE; DISEASE DURATION; DRUG EFFICACY; FEVER; FUNDING; GEOGRAPHIC DISTRIBUTION; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HELP SEEKING BEHAVIOR; HUMAN; INCIDENCE; MALARIA; MALARIA CONTROL; MONOTHERAPY; MORTALITY; MULTICENTER STUDY (TOPIC); NONMALARIAL FEBRILE ILLNESS; PERSONNEL SHORTAGE; PRESCRIPTION; PRIVATE PRACTICE; RAPID DIAGNOSTIC TEST; RAPID TEST; REVIEW; RISK REDUCTION; STAFF TRAINING; TREATMENT INDICATION; WORLD HEALTH ORGANIZATION;

AFRICA SOUTH OF THE SAHARA; ANTIMALARIALS; COMMUNITY HEALTH WORKERS; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; GEOGRAPHY; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALARIA; PRIVATE SECTOR;

EID: 84875529292     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2013.01.005     Document Type: Review

References (112)

1. World Health Organisation, (2011) World Malaria Report: Global Malaria Programme, World Health Organisation.
2. Stratton L., et al. The persistent problem of malaria: addressing the fundamental causes of a global killer. Soc. Sci. Med. 2008, 67:854-862.
3. de Savigny D., et al. Systems Thinking for Health Systems Strengthening 2009, World Health Organisation.
4. Alonso P.L., et al. A research agenda for malaria eradication: health systems and operational research. PLoS Med. 2011, 8:e1000397.
5. Tanner M., et al. From the efficacy of disease control tools to community effectiveness. Case studies from the biomedical and health systems research activities of the Swiss Tropical Institute in Africa. Trans. R. Soc. Trop. Med. 1993, 87:518-523.
6. Okwaraji Y.B., et al. Effect of geographical access to health facilities on child mortality in rural Ethiopia: a community based cross sectional study. PLoS ONE 2012, 7:e33564.
7. Feikin D.R., et al. The impact of distance of residence from a peripheral health facility on pediatric health utilisation in rural western Kenya. Trop. Med. Int. Health 2009, 14:54-61.
8. Roll Back Malaria Global Strategic Plan: Roll Back Malaria 2005-2015 2005, Roll Back Malaria Partnership.
9. Stock R. Distance and the utilization of health facilities in rural Nigeria. Soc. Sci. Med. 1983, 17:563-570.
10. Getahun A., et al. Determinants of delay in malaria treatment-seeking behaviour for under-five children in south-west Ethiopia: a case control study. Malar. J. 2010, 9:320.
11. Greenwood B.M., et al. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans. R. Soc. Trop. Med. Hyg. 1987, 81:478-486.
12. O'Meara W.P., et al. The impact of primary health care on malaria morbidity - defining access by disease burden. Trop. Med. Int. Health 2009, 14:29-35.
13. Al-Taiar A., et al. Who develops severe malaria? Impact of access to healthcare, socio-economic and environmental factors on children in Yemen: a case-control study. Trop. Med. Int. Health 2008, 13:762-770.
14. Mueller I., et al. Epidemic malaria in the highlands of Papua New Guinea. Am. J. Trop. Med. Hyg. 2005, 72:554-560.
15. Raso G., et al. Disparities in parasitic infections, perceived ill health and access to health care among poorer and less poor schoolchildren of rural Cote d'Ivoire. Trop. Med. Int. Health 2005, 10:42-57.
16. Chuma J., et al. Barriers to prompt and effective malaria treatment among the poorest population in Kenya. Malar. J. 2010, 9:144.
17. Wasunna B., et al. Why don't health workers prescribe ACT?. A qualitative study of factors affecting the prescription of artemether-lumefantrine. Malar. J. 2008, 7:29.
18. Wasunna B., et al. Health worker performance in the management of paediatric fevers following in-service training and exposure to job aids in Kenya. Malar. J. 2010, 9:261.
19. Hamer D.H., et al. Improved diagnostic testing and malaria treatment practices in Zambia. JAMA 2007, 297:2227-2231.
20. Zurovac D., et al. Malaria case-management under artemether-lumefantrine treatment policy in Uganda. Malar. J. 2008, 7:181.
21. Zurovac D., et al. Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya. Trop. Med. Int. Health 2008, 13:99-107.
22. Rowe A.K., et al. Quality of malaria case management at outpatient health facilities in Angola. Malar. J. 2009, 8:275.
23. Njogu J., et al. Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya. East Afr. Med. J. 2008, 85:213-221.
24. World Health Organisation Everybody's Business: Strengthening Health Systems to Improve Health Outcomes: WHO's Framework for Action 2007, World Health Organisation.
25. Cameron A., et al. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 2009, 373:240-249.
26. Zurovac D., et al. Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study. Malar. J. 2007, 6:31.
27. Kangwana B.B., et al. Malaria drug shortages in Kenya: a major failure to provide access to effective treatment. Am. J. Trop. Med. Hyg. 2009, 80:737-738.
28. Nyandigisi A., et al. Malaria case-management following change of policy to universal parasitological diagnosis and targeted artemisinin-based combination therapy in Kenya. PLoS ONE 2011, 6:e24781.
29. O'Connell K.A., et al. Got ACTs availability, price, market share and provider knowledge of anti-malaria medicines in public and private sector outlets in six malaria-endemic countries. Malar. J. 2011, 10:327.
30. Uzochukwu B.S., et al. Examining appropriate diagnosis and treatment of malaria: availability and use of rapid diagnostic tests and artemisinin-based combination therapy in public and private health facilities in south east Nigeria. BMC Public Health 2010, 10:486.
31. Noor A.M., et al. Health service providers in Somalia: their readiness to provide malaria case-management. Malar. J. 2009, 8:100.
32. Lufesi N.N., et al. Deficient supplies of drugs for life threatening diseases in an African community. BMC Health Serv. Res. 2007, 7:86.
33. Windisch R., et al. Scaling up antiretroviral therapy in Uganda: using supply chain management to appraise health systems strengthening. Global Health 2011, 7:25.
34. Hensen B., et al. Taking stock: provider prescribing practices in the presence and absence of ACT stock. Malar. J. 2011, 10:218.
35. Reyburn H., et al. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ 2004, 329:1212.
36. Zurovac D., et al. Effects of revised diagnostic recommendations on malaria treatment practices across age groups in Kenya. Trop. Med. Int. Health 2008, 13:784-787.
37. Nicastri E., et al. Accuracy of malaria diagnosis by microscopy, rapid diagnostic test, and PCR methods and evidence of antimalarial overprescription in non-severe febrile patients in two Tanzanian hospitals. Am. J. Trop. Med. Hyg. 2009, 80:712-717.
38. Nankabirwa J., et al. Malaria misdiagnosis in Uganda - implications for policy change. Malar. J. 2009, 8:66.
39. Okebe J.U., et al. Prescribing practice for malaria following introduction of artemether-lumefantrine in an urban area with declining endemicity in West Africa. Malar. J. 2010, 9:180.
40. Bastiaens G.J., et al. Malaria diagnostic testing and treatment practices in three different Plasmodium falciparum transmission settings in Tanzania: before and after a government policy change. Malar. J. 2011, 10:76.
41. Alba S., et al. Improvements in access to malaria treatment in Tanzania following community, retail sector and health facility interventions - a user perspective. Malar. J. 2010, 9:163.
42. Abuya T.O., et al. Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions. Malar. J. 2007, 6:57.
43. Kangwana B.P., et al. The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial. PLoS Med. 2011, 8:e1000437.
44. Amin A.A., et al. The use of formal and informal curative services in the management of paediatric fevers in four districts in Kenya. Trop. Med. Int. Health 2003, 8:1143-1152.
45. Alba S., et al. Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective. Malar. J. 2010, 9:164.
46. Patouillard E., et al. Retail sector distribution chains for malaria treatment in the developing world: a review of the literature. Malar. J. 2010, 9:50.
47. Goodman C., et al. Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved?. Am. J. Trop. Med. Hyg. 2007, 77:203-218.
48. Rowa Y., et al. Factors influencing implementation of the Ministry of Health-led private medicine retailer programmes on malaria in Kenya. BMC Public Health 2010, 10:93.
49. Goodman C., et al. Drug shop regulation and malaria treatment in Tanzania - why do shops break the rules, and does it matter?. Health Policy Plan. 2007, 22:393-403.
50. Ringsted F.M., et al. Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT). Malar. J. 2011, 10:238.
51. Littrell M., et al. Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries. Malar. J. 2011, 10:327.
52. Littrell M., et al. Case management of malaria fever in Cambodia: results from national anti-malarial outlet and household surveys. Malar. J. 2011, 10:328.
53. Sumba P.O., et al. Malaria treatment-seeking behaviour and recovery from malaria in a highland area of Kenya. Malar. J. 2008, 7:245.
54. Abuya T.O., et al. Evaluating different dimensions of programme effectiveness for private medicine retailer malaria control interventions in Kenya. PLoS ONE 2010, 5:e8937.
55. Chandler C.I., et al. Introducing malaria rapid diagnostic tests at registered drug shops in Uganda: limitations of diagnostic testing in the reality of diagnosis. Soc. Sci. Med. 2011, 72:937-944.
56. Mbonye A.K., et al. The feasibility of introducing rapid diagnostic tests for malaria in drug shops in Uganda. Malar. J. 2010, 9:367.
57. Kaur H., et al. A nationwide survey of the quality of antimalarials in retail outlets in Tanzania. PLoS ONE 2008, 3:e3403.
58. Bate R., et al. Antimalarial drug quality in the most severely malarious parts of Africa - a six country study. PLoS ONE 2008, 3:e2132.
59. Newton P.N., et al. Counterfeit anti-infective drugs. Lancet Infect. Dis. 2006, 6:602-613.
60. AMFm (2012) Independent Evaluation of Phase 1 of the Affordable Medicines Facility-malaria (AMFm), Multi-country Independent Evaluation Report: Final Report, ICF International and London School of Hygiene and Tropical Medicine.
61. World Bank Project Report: Stronger Drug Supply Chains Can Save Thousands of Children in Zambia and Beyond 2010, World Bank. http://go.worldbank.org/V61HKWLUQ1.
62. Asiimwe C., et al. Use of an innovative, affordable, and open-source short message service-based tool to monitor malaria in remote areas of Uganda. Am. J. Trop. Med. Hyg. 2011, 85:26-33.
63. Barrington J., et al. SMS for Life: a pilot project to improve anti-malarial drug supply management in rural Tanzania using standard technology. Malar. J. 2010, 9:298.
64. Githinji S., et al. Reducing stock-outs of life saving malaria commodities using mobile phone text-messaging: SMS for Life study in Kenya. PLoS ONE 2013, 8:e54066.
65. Tougher S., et al. Effect of the Affordable Medicines Facility-malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data. Lancet 2012, 380:1916-1926.
66. World Health Organisation Guidelines for the Treatment of Malaria 2010, World Health Organisation. 2nd edn.
67. Juma E., et al. Changes in health workers' malaria diagnosis and treatment practices in Kenya. Malar. J. 2011, 10:1.
68. Ishengoma D.S., et al. Accuracy of malaria rapid diagnostic tests in community studies and their impact on treatment of malaria in an area with declining malaria burden in north-eastern Tanzania. Malar. J. 2011, 10:176.
69. Skarbinski J., et al. Effect of malaria rapid diagnostic tests on the management of uncomplicated malaria with artemether-lumefantrine in Kenya: a cluster randomized trial. Am. J. Trop. Med. Hyg. 2009, 80:919-926.
70. Masanja I.M., et al. Increased use of malaria rapid diagnostic tests improves targeting of anti-malarial treatment in rural Tanzania: implications for nationwide rollout of malaria rapid diagnostic tests. Malar. J. 2012, 11:221.
71. d'Acremont V., et al. Reduction of anti-malarial consumption after rapid diagnostic tests implementation in Dar es Salaam: a before-after and cluster randomized controlled study. Malar J 2011, 10:107.
72. Msellem M.I., et al. Influence of rapid malaria diagnostic tests on treatment and health outcome in fever patients, Zanzibar: a crossover validation study. PLoS Med. 2009, 6:e1000070.
73. Sserwanga A., et al. Improved malaria case management through the implementation of a health facility-based sentinel site surveillance system in Uganda. PLoS ONE 2011, 6:e16316.
74. Kyabayinze D.J., et al. Use of RDTs to improve malaria diagnosis and fever case management at primary health care facilities in Uganda. Malar. J. 2010, 9:200.
75. Ansah E.K., et al. Rapid testing for malaria in settings where microscopy is available and peripheral clinics where only presumptive treatment is available: a randomised controlled trial in Ghana. BMJ 2010, 340:c930.
76. Mtove G., et al. Treatment guided by rapid diagnostic tests for malaria in Tanzanian children: safety and alternative bacterial diagnoses. Malar. J. 2011, 10:290.
77. d'Acremont V., et al. Withholding antimalarials in febrile children who have a negative result for a rapid diagnostic test. Clin. Infect. Dis. 2010, 51:506-511.
78. Njama-Meya D., et al. Treatment of malaria restricted to laboratory-confirmed cases: a prospective cohort study in Ugandan children. Malar. J. 2007, 6:7.
79. Mosha J.F., et al. Cost implications of improving malaria diagnosis: findings from north-eastern Tanzania. PLoS ONE 2010, 5:e8707.
80. Batwala V., et al. Cost-effectiveness of malaria microscopy and rapid diagnostic tests versus presumptive diagnosis: implications for malaria control in Uganda. Malar. J. 2011, 10:372.
81. Zurovac D., et al. Modeling the financial and clinical implications of malaria rapid diagnostic tests in the case-management of older children and adults in Kenya. Am. J. Trop. Med. Hyg. 2008, 78:884-891.
82. Smith L.A., et al. Provider practice and user behavior interventions to improve prompt and effective treatment of malaria: do we know what works?. Am. J. Trop. Med. Hyg. 2009, 80:326-335.
83. Ngasala B., et al. Impact of training in clinical and microscopy diagnosis of childhood malaria on antimalarial drug prescription and health outcome at primary health care level in Tanzania: a randomized controlled trial. Malar. J. 2008, 7:199.
84. Rowe A.K., et al. A multifaceted intervention to improve health worker adherence to integrated management of childhood illness guidelines in Benin. Am. J. Public Health 2009, 99:837-846.
85. Christopher J.B., et al. Thirty years after Alma-Ata: a systematic review of the impact of community health workers delivering curative interventions against malaria, pneumonia and diarrhoea on child mortality and morbidity in sub-Saharan Africa. Hum. Resour. Health 2011, 9:27.
86. Guenther T., et al. Beyond distance: an approach to measure effective access to case management for sick children in Africa. Am. J. Trop. Med. Hyg. 2012, 87:77-84.
87. Hopkins H., et al. Impact of home-based management of malaria on health outcomes in Africa: a systematic review of the evidence. Malar. J. 2007, 6:134.
88. Akweongo P., et al. Feasibility and acceptability of ACT for the community case management of malaria in urban settings in five African sites. Malar. J. 2011, 10:240.
89. Staedke S.G., et al. Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial. Lancet 2009, 373:1623-1631.
90. Chinbuah M.A., et al. Impact of community management of fever (using antimalarials with or without antibiotics) on childhood mortality: a cluster-randomized controlled trial in Ghana. Am. J. Trop. Med. Hyg. 2012, 87:11-20.
91. Kalyango J.N., et al. Increased use of community medicine distributors and rational use of drugs in children less than five years of age in Uganda caused by integrated community case management of fever. Am. J. Trop. Med. Hyg. 2012, 87:36-45.
92. Rutebemberwa E., et al. Use of community health workers for management of malaria and pneumonia in urban and rural areas in eastern Uganda. Am. J. Trop. Med. Hyg. 2012, 87:30-35.
93. Yeboah-Antwi K., et al. Community case management of fever due to malaria and pneumonia in children under five in Zambia: a cluster randomized controlled trial. PLoS Med. 2010, 7:e1000340.
94. Seidenberg P.D., et al. Impact of integrated community case management on health-seeking behavior in rural Zambia. Am. J. Trop. Med. Hyg. 2012, 87:105-110.
95. Elmardi K.A., et al. Feasibility and acceptability of home-based management of malaria strategy adapted to Sudan's conditions using artemisinin-based combination therapy and rapid diagnostic test. Malar. J. 2009, 8:39.
96. Mukanga D., et al. Access, acceptability and utilization of community health workers using diagnostics for case management of fever in Ugandan children: a cross-sectional study. Malar. J. 2012, 11:121.
97. Lemma H., et al. Deploying artemether-lumefantrine with rapid testing in Ethiopian communities: impact on malaria morbidity, mortality and healthcare resources. Trop. Med. Int. Health 2010, 15:241-250.
98. Mukanga D., et al. Integrated community case management of fever in children under five using rapid diagnostic tests and respiratory rate counting: a multi-country cluster randomized trial. Am. J. Trop. Med. Hyg. 2012, 87:21-29.
99. Mubi M., et al. Malaria rapid testing by community health workers is effective and safe for targeting malaria treatment: randomised cross-over trial in Tanzania. PLoS ONE 2011, 6:e19753.
100. Tine R.C., et al. Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial. Malar. J. 2011, 10:358.
101. Chanda P., et al. Relative costs and effectiveness of treating uncomplicated malaria in two rural districts in Zambia: implications for nationwide scale-up of home-based management. Malar. J. 2011, 10:159.
102. Sabot O.J., et al. Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania. PLoS ONE 2009, 4:e6857.
103. Cohen J.M., et al. A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops. BMC Health Serv. Res. 2010, 10(Suppl. 1):S6.
104. Smith N., et al. Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme. Malar. J. 2011, 10:316.
105. Talisuna A.O., et al. Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study. Malar. J. 2012, 11:356.
106. Barnes K.I., et al. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. Malar. J. 2009, 8(Suppl. 1):S8.
107. Bhattarai A., et al. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med. 2007, 4:e309.
108. Binka F., et al. Modeling the benefits of implementing MFL treatments in Ghana within high and low transmission settings. INESS INDEPTH effectiveness and Safety study sites for antimalarials (INESS). American Society of Tropical Medicine and Hygiene Conference 2012 2012.
109. Gomes M.F., et al. Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet. 2009, 373:557-566.
110. Zurovac D., et al. Mobile phone text messaging: tool for malaria control in Africa. PLoS Med. 2012, 9:e1001176.
111. Okell L.C., et al. Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med. 2008, 5:e226.
112. Gosling R., et al. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2009, 374:1521-1532.